Panchsheel Organics Ltd

Panch.Organics Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Panchsheel Organics Ltd

₹ 136 1.83%
05 Dec - close price
panchsheelorganics.com BSE: 531726
About

Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]

Key Points

Business Overview:[1]
POL is a part of Turakhia Bros group. It is a WHO Compliant, ISO and GMP certified manufacturer and exporter of a range of APIs, Intermediates, Nutraceutical, Vitamins Hormones, Steroids, Finished Formulations (Human & Veterinary), Agri Biotech range (Bio Fertilizers, Bio Stimulants,Growth Promoters), Aqua Culture, Dehydrated Culture Media

Website BSE
  • Market Cap ₹ 179 Cr.
  • Current Price ₹ 136
  • High / Low ₹ 234 / 126
  • Stock P/E 14.6
  • Book Value ₹ 105
  • Dividend Yield 2.35 %
  • ROCE 13.6 %
  • ROE 10.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 21.1% CAGR over last 5 years

Cons

  • Company has a low return on equity of 13.5% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
24.33 27.96 29.53 24.63 23.71 25.61 31.27 26.05 27.18 26.24 28.37 23.56 25.32
19.02 22.24 25.58 19.75 19.28 20.70 26.54 21.62 22.05 21.70 23.60 19.81 21.82
Operating Profit 5.31 5.72 3.95 4.88 4.43 4.91 4.73 4.43 5.13 4.54 4.77 3.75 3.50
OPM % 21.82% 20.46% 13.38% 19.81% 18.68% 19.17% 15.13% 17.01% 18.87% 17.30% 16.81% 15.92% 13.82%
0.00 0.01 1.17 0.10 1.01 1.22 0.13 0.74 0.70 0.96 0.00 0.66 0.64
Interest 0.09 0.18 0.23 0.07 0.11 0.05 0.05 0.06 0.14 0.08 0.09 0.06 0.08
Depreciation 0.31 0.31 0.64 0.38 0.41 0.39 0.56 0.54 0.56 0.58 0.51 0.56 0.58
Profit before tax 4.91 5.24 4.25 4.53 4.92 5.69 4.25 4.57 5.13 4.84 4.17 3.79 3.48
Tax % 25.25% 25.19% 30.12% 25.17% 25.20% 25.13% 34.59% 24.95% 26.12% 24.17% 23.98% 25.07% 25.00%
3.67 3.92 2.99 3.39 3.69 4.26 2.78 3.43 3.79 3.67 3.17 2.85 2.61
EPS in Rs 3.11 3.33 2.54 2.88 3.13 3.62 2.11 2.60 2.88 2.79 2.41 2.16 1.98
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
39 36 40 40 42 48 50 49 69 103 105 107 103
35 31 34 33 35 41 42 41 56 83 86 90 87
Operating Profit 4 5 6 7 7 7 9 9 13 20 19 18 17
OPM % 11% 13% 14% 17% 16% 14% 17% 18% 19% 19% 18% 16% 16%
0 0 0 0 0 0 0 0 0 1 2 3 2
Interest 1 1 1 0 1 0 0 0 0 1 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 2 2 2 2
Profit before tax 3 3 4 5 5 6 7 7 11 19 19 18 16
Tax % 35% 32% 27% 36% 29% 29% 28% 31% 27% 26% 27% 24%
2 2 3 3 4 4 5 5 8 14 14 14 12
EPS in Rs 1.76 1.90 3.04 3.21 3.67 4.04 5.29 5.01 8.33 11.94 10.71 10.47 9.34
Dividend Payout % 14% 13% 17% 16% 14% 12% 0% 20% 18% 7% 7% 8%
Compounded Sales Growth
10 Years: 12%
5 Years: 16%
3 Years: 16%
TTM: -6%
Compounded Profit Growth
10 Years: 22%
5 Years: 21%
3 Years: 18%
TTM: -14%
Stock Price CAGR
10 Years: 10%
5 Years: 28%
3 Years: -22%
1 Year: -40%
Return on Equity
10 Years: 14%
5 Years: 14%
3 Years: 13%
Last Year: 11%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5 5 5 5 5 5 5 5 10 12 13 13 13
Reserves 12 13 16 19 22 25 30 35 37 84 112 121 125
5 7 5 7 6 5 4 4 4 6 6 5 4
12 8 11 9 12 9 12 14 22 21 28 24 29
Total Liabilities 35 33 37 39 44 44 52 58 74 123 159 163 171
8 7 7 8 7 7 6 7 7 8 14 18 19
CWIP 0 0 2 2 2 2 2 2 2 4 6 15 17
Investments 0 0 0 0 0 0 0 0 0 0 3 0 0
28 26 28 30 36 36 44 49 65 111 137 131 135
Total Assets 35 33 37 39 44 44 52 58 74 123 159 163 171

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3 1 3 1 3 2 5 5 -2 0 10 4
-1 -1 -2 -2 -1 -1 -2 -1 -0 -34 -7 -16
-2 0 -1 1 -2 -2 -1 -2 -1 36 16 -5
Net Cash Flow 0 0 -1 0 -0 0 1 3 -2 1 18 -18

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 130 142 134 138 170 137 164 140 172 137 137 119
Inventory Days 124 154 155 185 185 164 186 246 237 181 211 246
Days Payable 108 80 109 83 124 73 111 152 158 89 114 88
Cash Conversion Cycle 146 216 181 240 231 229 239 235 251 230 234 276
Working Capital Days 104 136 138 137 150 155 170 167 192 173 178 204
ROCE % 15% 14% 19% 20% 18% 18% 20% 19% 25% 26% 17% 14%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
58.08% 58.08% 58.08% 58.08% 58.08% 58.08% 56.12% 56.12% 56.12% 56.12% 56.12% 56.12%
0.12% 0.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.14% 1.14% 0.98% 0.00% 0.00%
41.81% 41.81% 41.93% 41.92% 41.93% 41.92% 43.87% 42.74% 42.74% 42.89% 43.87% 43.87%
No. of Shareholders 5,8175,8426,2406,7948,0738,1407,9607,8548,0928,2488,3448,783

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Nov 2023
    Transcript
    AI Summary
    PPT
  • Dec 2022
    Transcript
    AI Summary
    PPT
  • Dec 2022
    Transcript
    AI Summary
    PPT
  • Jun 2022
    Transcript
    AI Summary
    PPT
  • Apr 2022
    Transcript
    AI Summary
    PPT
  • Apr 2022
    Transcript
    AI Summary
    PPT
  • Apr 2022
    Transcript
    AI Summary
    PPT